Astrana Health, Inc. Stockholders Equity

Quick Answer

Astrana Health, Inc. reported Stockholders Equity of $779.29 million for the year ending 2025.

  • Astrana Health, Inc. showed an increase of +9.3% in Stockholders Equity from 2024 to 2025.
  • This data is from Astrana Health, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
  • XBRL data for this metric is available from 2011 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q3 2011: -$375.4 thousand | Q4 2011: -$239.9 thousand | Q2 2012: -$594.4 thousand | Q3 2012: -$3.75 million | Q4 2012: -$59.8 thousand | Q2 2013: -$901.5 thousand | Q3 2013: -$999.3 thousand | Q4 2013: -$779.2 thousand | Q2 2014: -$2.76 million | Q3 2014: -$375.8 thousand | Q4 2014: -$1.95 million | Q4 2015: -$4.62 million | Q2 2016: -$2.20 million | Q3 2016: -$3.28 million | Q1 2017: -$353.9 thousand | Q2 2017: -$3.74 million | Q3 2017: -$7.34 million | Q1 2018: $165.67 million | Q2 2018: $169.62 million | Q3 2018: $179.94 million | Q1 2019: $180.97 million | Q2 2019: $185.40 million | Q3 2019: $190.73 million | Q1 2020: $197.08 million | Q2 2020: $207.02 million | Q3 2020: $228.40 million | Q1 2021: $349.09 million | Q2 2021: $401.36 million | Q3 2021: $435.90 million | Q1 2022: $473.99 million | Q2 2022: $479.97 million | Q3 2022: $510.44 million | Q1 2023: $560.04 million | Q2 2023: $566.01 million | Q3 2023: $593.71 million | Q1 2024: $653.49 million | Q2 2024: $678.87 million | Q3 2024: $704.62 million | Q1 2025: $745.37 million | Q2 2025: $765.46 million | Q3 2025: $775.54 million.
  • Over the full 18 years of available data (2011 to 2025), Astrana Health, Inc.'s Stockholders Equity has grown by 250,427.2%.
  • Historical annual values: Fiscal year 2025: $779.29 million | Fiscal year 2024: $712.72 million | Fiscal year 2023: $614.22 million | Fiscal year 2022: $542.56 million | Fiscal year 2021: $454.55 million | Fiscal year 2020: $330.82 million | Fiscal year 2019: $191.55 million | Fiscal year 2018: $180.55 million | Fiscal year 2017: $159.95 million | Fiscal year 2017: -$353.9 thousand | Fiscal year 2016: $87.21 million | Fiscal year 2016: -$1.27 million | Fiscal year 2015: -$2.82 million | Fiscal year 2014: -$2.41 million | Fiscal year 2014: -$2.62 million | Fiscal year 2013: -$354.9 thousand | Fiscal year 2012: -$659.3 thousand | Fiscal year 2011: -$311.3 thousand.
  • Data sourced from SEC EDGAR public filings as of August 5, 2026.

Last verified: